
Figure 1
Map of the informal settlements supported by Doctors with Africa CUAMM.
Table 1
Absolute distribution and percentage of patients at the first visit by gender and location.
| GENDER SETTLEMENT | MALE 2,430 (95.8%) | FEMALE 107 (4.2%) | TOTAL 2,537 (%) |
|---|---|---|---|
| Arena (A) | 275 (99.6%) | 1 (0.4%) | 276 (10.9%) |
| Barletta (B) | 15 (100%) | 0 (0%) | 15 (0.6%) |
| Borgo Tressanti (C) | 50 (73.5%) | 18 (26.5%) | 68 (2.7%) |
| Contrada Cicerone (D) | 167 (99.4%) | 1 (0.6%) | 168 (6.6%) |
| Madonna di Ripalta (E) | 78 (95.1%) | 4 (4.9%) | 82 (3.2%) |
| Pista (F) | 773 (91.7%) | 70 (8.3%) | 843 (33.2%) |
| San Carlo d’Ascoli (G) | 7 (100%) | 0 (0%) | 7 (0.3%) |
| Sankara (H) | 643 (98.9%) | 7 (1.1%) | 650 (25.6%) |
| Terlizzi (I) | 63 (100%) | 0 (0%) | 63 (2.5%) |
| Terraneo (J) | 90 (93.8%) | 6 (6.3%) | 96 (3.8%) |
| Turi (K) | 223 (100%) | 0 (0%) | 223 (8.8%) |
| Uliveto (L) | 46 (100%) | 0 (0%) | 46 (1.8%) |

Figure 2
Gender distribution.
Table 2
Distribution of patient nationalities by settlement.
| SETTLEMENT NATIONALITY | N (%) | A | B | C | D | E | F | G | H | I | J | K | L |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Afghanistan | 14 (0.55%) | 0 | 0 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algeria | 7 (0.28%) | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 |
| Bangladesh | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belgium | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Benin | 17 (0.67%) | 8 | 0 | 0 | 0 | 0 | 5 | 0 | 4 | 0 | 0 | 0 | 0 |
| Bulgaria | 29 (1.14%) | 0 | 0 | 28 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Burkina Faso | 109 (4.3%) | 1 | 0 | 0 | 2 | 62 | 8 | 2 | 3 | 0 | 31 | 0 | 0 |
| Cameroon | 8 (0.32%) | 0 | 0 | 0 | 0 | 1 | 3 | 0 | 4 | 0 | 0 | 0 | 0 |
| Chad | 4 (0.16%) | 1 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Congo | 3 (0.12%) | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ivory Coast | 86 (3.39%) | 16 | 0 | 0 | 28 | 4 | 20 | 0 | 16 | 0 | 2 | 0 | 0 |
| Ethiopia | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gambia | 523 (20.61%) | 101 | 0 | 0 | 0 | 0 | 168 | 0 | 251 | 0 | 2 | 1 | 0 |
| Ghana | 33 (1.3%) | 2 | 0 | 0 | 1 | 0 | 21 | 0 | 2 | 0 | 7 | 0 | 0 |
| Guinea‑Bissau | 31 (1.22%) | 4 | 0 | 0 | 1 | 0 | 16 | 0 | 10 | 0 | 0 | 0 | 0 |
| Guinea‑Conakry | 110 (4.34%) | 11 | 0 | 0 | 13 | 1 | 55 | 0 | 30 | 0 | 0 | 0 | 0 |
| India | 5 (0.2%) | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Italy | 3 (0.12%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Liberia | 3 (0.12%) | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Libya | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Mali | 254 (10.01%) | 42 | 0 | 0 | 103 | 4 | 54 | 1 | 44 | 0 | 5 | 1 | 0 |
| Morocco | 344 (13.56%) | 0 | 2 | 26 | 0 | 0 | 2 | 1 | 1 | 55 | 6 | 209 | 42 |
| Mauritania | 3 (0.12%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Mauritius | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Somalia (Mogadishu) | 1 (0.04%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nigeria | 137 (5.4%) | 1 | 0 | 0 | 0 | 0 | 112 | 0 | 10 | 0 | 14 | 0 | 0 |
| Pakistan | 8 (0.32%) | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Poland | 9 (0.35%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8 | 0 | 0 |
| Punjab (India/Pakistan) | 2 (0.08%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Romania | 24 (0.95%) | 0 | 0 | 7 | 0 | 0 | 0 | 3 | 0 | 0 | 14 | 0 | 0 |
| Senegal | 686 (27.04%) | 85 | 0 | 0 | 15 | 1 | 315 | 0 | 263 | 0 | 3 | 4 | 0 |
| Sierra Leone | 11 (0.43%) | 2 | 0 | 0 | 0 | 0 | 5 | 0 | 4 | 0 | 0 | 0 | 0 |
| Somalia | 15 (0.59%) | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sudan | 3 (0.12%) | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Togo | 3 (0.12%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Tunisia | 26 (1.02%) | 0 | 12 | 5 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 2 | 1 |
| Not available | 21 (0.83%) | 2 | 0 | 1 | 0 | 0 | 8 | 0 | 4 | 2 | 1 | 0 | 3 |
[i] A = Arena; B = Barletta; C = Borgo Tressanti; D = Contrada Cicerone; E = Madonna di Ripalta; F = Pista; G = San Carlo d’Ascoli; H = Sankara; I = Terlizzi; J = Terraneo; K = Turi; L = Uliveto.

Figure 3
Countries of origins.
Table 3
Distribution by settlement of age at first visit, presence of residence permit, presence of GP, and year of first visit.
| AGE IN YEARS | TOTAL (%) | A | B | C | D | E | F | G | H | I | J | K | L |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–18 | 42 (1.66%) | 1 | 0 | 8 | 0 | 6 | 4 | 0 | 3 | 1 | 9 | 1 | 9 |
| 19–29 | 783 (30.86%) | 88 | 7 | 8 | 31 | 13 | 288 | 1 | 242 | 41 | 10 | 36 | 18 |
| 30–45 | 1,327 (52.31%) | 169 | 6 | 34 | 118 | 31 | 454 | 3 | 345 | 14 | 38 | 103 | 12 |
| 46–65 | 317 (12.50%) | 12 | 2 | 14 | 18 | 32 | 72 | 2 | 51 | 6 | 35 | 71 | 2 |
| Over 65 | 19 (0.75%) | 0 | 0 | 2 | 0 | 0 | 6 | 1 | 4 | 1 | 1 | 4 | 0 |
| Not available | 49 (1.93%) | 6 | 0 | 2 | 1 | 0 | 19 | 0 | 5 | 0 | 3 | 8 | 5 |
| Median | 29.7 | 29.5 | 28.9 | 35.6 | 32.6 | 40.2 | 26.9 | 45.0 | 28.9 | 26.0 | 39.8 | 36.7 | 25.5 |
| Average (SD) | 31.8 (10.4) | 30.7 (6.8) | 31.1 (8.3) | 35.6 (14.3) | 34.00 (7.8) | 39.2 (13.9) | 28.9 (8.4) | 49.5 (21.2) | 30.9 (8.7) | 29.7 (9.8) | 39.1 (14.8) | 39.5 (13.4) | 29.1 (12.6) |
| RESIDENCE PERMIT | TOTAL (%) | A | B | C | D | E | F | G | H | I | J | K | L |
| Absent | 2,083 (82.10%) | 191 | 15 | 60 | 71 | 69 | 838 | 7 | 452 | 59 | 62 | 210 | 46 |
| Present | 454 (17.90%) | 85 | 0 | 8 | 97 | 13 | 5 | 0 | 198 | 4 | 34 | 13 | 0 |
| GENERAL PRATICTIONER | TOTAL (%) | A | B | C | D | E | F | G | H | I | J | K | L |
| Absent | 2,352 (92.71%) | 258 | 15 | 66 | 160 | 82 | 733 | 7 | 614 | 63 | 89 | 221 | 44 |
| Present | 185 (7.29%) | 18 | 0 | 2 | 8 | 0 | 110 | 0 | 36 | 0 | 7 | 2 | 2 |
| YEAR OF FIRST VISIT | TOTAL (%) | A | B | C | D | E | F | G | H | I | J | K | L |
| 2017 | 97 (3.82%) | 16 | 0 | 0 | 0 | 0 | 33 | 0 | 48 | 0 | 0 | 0 | 0 |
| 2018 | 574 (22.63%) | 41 | 0 | 0 | 0 | 0 | 408 | 0 | 125 | 0 | 0 | 0 | 0 |
| 2019 | 447 (17.62%) | 26 | 0 | 0 | 0 | 0 | 334 | 0 | 87 | 0 | 0 | 0 | 0 |
| 2020 | 465 (18.33%) | 111 | 0 | 0 | 62 | 0 | 68 | 0 | 190 | 0 | 34 | 0 | 0 |
| 2021 | 243 (9.58%) | 43 | 0 | 0 | 74 | 0 | 0 | 0 | 77 | 0 | 49 | 0 | 0 |
| 2022 | 338 (13.32%) | 17 | 15 | 0 | 19 | 53 | 0 | 1 | 60 | 0 | 12 | 161 | 0 |
| 2023 | 373 (14.70%) | 22 | 0 | 68 | 13 | 29 | 0 | 6 | 63 | 63 | 1 | 62 | 46 |
[i] A = Arena; B = Barletta; C = Borgo Tressanti; D = Contrada Cicerone; E = Madonna di Ripalta; F = Pista; G = San Carlo d’Ascoli; H = Sankara; I = Terlizzi; J = Terraneo; K = Turi; L = Uliveto.
Table 4
Distribution by location of clinical characteristics recorded at the first visit.
| PATHOLOGY | TOTAL (%) | A | B | C | D | E | F | G | H | I | J | K | L |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes | |||||||||||||
| Absent | 2,514 (99.09%) | 273 | 15 | 66 | 167 | 82 | 840 | 7 | 644 | 62 | 93 | 221 | 44 |
| Present | 23 (0.91%) | 3 | 0 | 2 | 1 | 0 | 3 | 0 | 6 | 1 | 3 | 2 | 2 |
| High blood pressure | |||||||||||||
| Absent | 2,448 (96.49%) | 269 | 15 | 65 | 158 | 79 | 831 | 5 | 620 | 63 | 83 | 215 | 45 |
| Present | 89 (3.51%) | 7 | 0 | 3 | 10 | 3 | 12 | 2 | 30 | 0 | 13 | 8 | 1 |
| “Fatigue” pathologies | |||||||||||||
| Absent | 2,036 (80.25%) | 229 | 15 | 56 | 134 | 64 | 624 | 5 | 531 | 52 | 84 | 206 | 36 |
| Present | 501 (19.75%) | 47 | 0 | 12 | 34 | 18 | 219 | 2 | 119 | 11 | 12 | 17 | 10 |
| Asthma or chronic bronchitis | |||||||||||||
| Absent | 2,507 (98.82%) | 273 | 15 | 67 | 168 | 82 | 836 | 7 | 636 | 63 | 96 | 220 | 44 |
| Present | 30 (1.18%) | 3 | 0 | 1 | 0 | 0 | 7 | 0 | 14 | 0 | 0 | 3 | 2 |
| Tubercolosis | |||||||||||||
| Absent | 2,515 (99.13%) | 274 | 15 | 68 | 168 | 82 | 837 | 7 | 637 | 63 | 96 | 222 | 46 |
| Present | 22 (0.87%) | 2 | 0 | 0 | 0 | 0 | 6 | 0 | 13 | 0 | 0 | 1 | 0 |
| HIV | |||||||||||||
| Absent | 2,531 (99.76%) | 273 | 15 | 68 | 167 | 81 | 843 | 7 | 649 | 63 | 96 | 223 | 46 |
| Present | 6 (0.24%) | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| HBV | |||||||||||||
| Absent | 2,528 (99.65%) | 273 | 15 | 68 | 168 | 82 | 841 | 7 | 646 | 63 | 96 | 223 | 46 |
| Present | 9 (0.35%) | 3 | 0 | 0 | 0 | 0 | 2 | 0 | 4 | 0 | 0 | 0 | 0 |
| HCV | |||||||||||||
| Absent | 2,534 (99.88%) | 275 | 15 | 68 | 168 | 82 | 843 | 7 | 648 | 63 | 96 | 223 | 46 |
| Present | 3 (0.12%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
[i] A = Arena; B = Barletta; C = Borgo Tressanti; D = Contrada Cicerone; E = Madonna di Ripalta; F = Pista; G = San Carlo d’Ascoli; H = Sankara; I = Terlizzi; J = Terraneo; K = Turi; L = Uliveto.
Table 5
Distribution of the number of visits by settlement.
| MALES N (%) 12,809 (97.8%) | FEMALE N (%) 294 (2.2%) | TOTAL N (%) 13,103 (100%) | AVERAGE NUMBER OF VISITS PER PATIENT 5.16 | |
|---|---|---|---|---|
| Arena | 2,647 (99.9%) | 3 (0.1%) | 2,650 (20.2%) | 9.6 |
| Barletta | 40 (100%) | 0 (0%) | 40 (0.3%) | 2.67 |
| Borgo Tressanti | 127 (66.1%) | 65 (33.9%) | 192 (1.5%) | 2.82 |
| Contrada Cicerone | 1,062 (99.7%) | 3 (0.3%) | 1,065 (8.1%) | 6.34 |
| Madonna di Ripalta | 410 (94%) | 26 (6%) | 436 (3.3%) | 5.32 |
| Pista | 1,517 (91.1%) | 148 (8.9%) | 1,665 (12.7%) | 1.98 |
| San Carlo d’Ascoli | 51 (100%) | 0 (0%) | 51 (0.4%) | 7.29 |
| Sankara | 5,281 (99.4%) | 34 (0.6%) | 5,315 (40.6%) | 8.18 |
| Terlizzi | 160 (100%) | 0 (0%) | 160 (1.2%) | 2.54 |
| Terraneo | 785 (98.1%) | 15 (1.9%) | 800 (6.1%) | 8.33 |
| Turi | 653 (100%) | 0 (0%) | 653 (5%) | 2.93 |
| Uliveto | 76 (100%) | 0 (0%) | 76 (0.6%) | 1.65 |

Figure 4
Pareto chart of total number of visits per patient.
Table 6
Distribution of pathologies by settlement.
| DIAGNOSIS N (%) | A 1,217 (17.9%) | B 18 (0.3%) | C 129 (1.9%) | D 461 (6.8%) | E 218 (3.2%) | F 1,170 (17.2%) | G 26 (0.4%) | H 2,710 (40%) | I 96 (1.4%) | J 331 (4.9%) | K 350 (5.2%) | L 57 (0.8%) | TOTAL 6,783 (100%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fatigue disorders (tiredness and osteoarticular disorders) | 297 (24.4%) | 5 (27.8%) | 36 (27.9%) | 125 (27.1%) | 82 (37.6%) | 334 (28.6%) | 11 (42.3%) | 775 (28.6%) | 23 (23.9%) | 66 (20.0%) | 86 (24.6%) | 16 (28.1%) | 1,856 (27.3%) |
| Gastrointestinal disorders | 180 (14.8%) | 1 (5.6%) | 11 (8.5%) | 81 (17.6%) | 23 (10.6%) | 225 (19.2%) | 0 (0%) | 412 (15.2%) | 4 (4.2%) | 14 (4.2%) | 47 (13.4%) | 2 (3.5%) | 1,000 (14.7%) |
| Airways pathologies | 158 (13%) | 2 (11.1%) | 21 (16.3%) | 52 (11.3%) | 19 (8.7%) | 207 (17.7%) | 1 (3.8%) | 421 (15.5%) | 19 (19.8%) | 21 (6.3%) | 37 (10.6%) | 9 (15.8%) | 967 (14.3%) |
| Dermatological | 174 (14.3%) | 4 (22.2%) | 8 (6.2%) | 90 (19.5%) | 22 (10.1%) | 120 (10.3%) | 1 (3.8%) | 279 (10.3%) | 25 (26%) | 41 (12.4%) | 46 (13.1%) | 13 (22.8%) | 823 (12.1%) |
| Cardiovascular | 70 (5.8%) | 2 (11.1%) | 15 (11.6%) | 44 (9.5%) | 37 (17%) | 31 (2.6%) | 10 (38.5%) | 201 (7.4%) | 0 (0%) | 119 (36%) | 24 (6.9%) | 2 (3.5%) | 555 (8.2%) |
| Dental problems | 109 (9%) | 1 (5.6%) | 7 (5.4%) | 26 (5.6%) | 5 (2.3%) | 103 (8.8%) | 0 (0%) | 186 (6.9%) | 8 (8.3%) | 9 (2.7%) | 32 (9.1%) | 4 (7%) | 490 (7.2%) |
| Traumas | 91 (7.5%) | 1 (5.6%) | 2 (1.6%) | 9 (2%) | 5 (2.3%) | 40 (3.4%) | 2 (7.7%) | 134 (4.9%) | 5 (5.2%) | 12 (3.6%) | 17 (4.9%) | 6 (10.5%) | 324 (4.8%) |
| Ophthalmological | 56 (4.6%) | 1 (5.6%) | 4 (3.1%) | 21 (4.6%) | 10 (4.6%) | 35 (3%) | 1 (3.8%) | 100 (3.7%) | 4 (4.2%) | 25 (7.6%) | 34 (9.7%) | 2 (3.5%) | 293 (4.3%) |
| Urinary tract | 31 (2.5%) | 0 (0%) | 2 (1.6%) | 3 (0.7%) | 5 (2.3%) | 31 (2.6%) | 0 (0%) | 31 (1.1%) | 0 (0%) | 4 (1.2%) | 10 (2.9%) | 0 (0%) | 117 (1.7%) |
| ENT pathologies | 20 (1.6%) | 1 (5.6%) | 2 (1.6%) | 4 (0.9%) | 5 (2.3%) | 5 (0.4%) | 0 (0%) | 42 (1.5%) | 1 (1%) | 0 (0%) | 6 (1.7%) | 0 (0%) | 86 (1.3%) |
| Diabetes and endocrinological disorders | 4 (0.3%) | 0 (0%) | 14 (10.9%) | 4 (0.9%) | 1 (0.5%) | 4 (0.3%) | 0 (0%) | 23 (0.8%) | 3 (3,1%) | 18 (5.4%) | 5 (1.4%) | 2 (3.5%) | 78 (1.2%) |
| Neuropsychiatric disorders | 16 (1%) | 0 (0%) | 5 (3.9%) | 1 (0.2%) | 1 (0.5%) | 5 (0.5%) | 0 (0%) | 31 (1.1%) | 3 (3.1%) | 2 (0.6%) | 5 (1.4%) | 1 (1.8%) | 70 (1.1%) |
| TB | 6 (0.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (0.5%) | 0 (0%) | 26 (1%) | 0 (0%) | 0 (0%) | 1 (0.3%) | 0 (0%) | 39 (0.6%) |
| Rheumatological | 2 (0.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.1%) | 0 (0%) | 35 (1.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 38 (0.6%) |
| Obstetric‑gynecological | 0 (0%) | 0 (0%) | 1 (0.8%) | 0 (0%) | 0 (0%) | 23 (2%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 24 (0.4%) |
| HIV | 3 (0.2%) | 0 (0%) | 0 (0%) | 1 (0.2%) | 3 (1.4%) | 0 (0%) | 0 (0%) | 2 (0.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 9 (0.1%) |
| Oncological | 0 (0%) | 0 (0%) | 1 (0.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (0.2%) | 1 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (0.1%) |
| Hematological | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (0.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (0.1%) |
[i] A = Arena; B = Barletta; C = Borgo Tressanti; D = Contrada Cicerone; E = Madonna di Ripalta; F = Pista; G = San Carlo d’Ascoli; H = Sankara; I = Terlizzi; J = Terraneo; K = Turi; L = Uliveto; ENT = ears, nose, and throat.
Table 7
Therapies administered.
| THERAPIES N (%) | A 1,217 (17.9%) | B 18 (0.3%) | C 129 (1.9%) | D 461 (6.8%) | E 218 (3.2%) | F 1,170 (17.2%) | G 26 (0.4%) | H 2,710 (40%) | I 96 (1.4%) | J 331 (4.9%) | K 350 (5.2%) | L 57 (0.8%) | TOTAL 6,783 (100%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NSAIDs, painkillers and cortisone | 394 (30.9%) | 5 (27.8%) | 29 (22.5%) | 132 (28.7%) | 66 (30.3%) | 478 (40.9%) | 10 (38.4%) | 951 (35.1%) | 33 (34.3%) | 70 (21.1%) | 97 (27.7%) | 7 (12.3%) | 2272 (33.6%) |
| Topicals (creams and eye drops) | 159 (13.1%) | 2 (11.1%) | 7 (5.4%) | 70 (15.2%) | 34 (15.6%) | 122 (10.4%) | 0 (0%) | 296 (10.9%) | 17 (17.7%) | 42 (12.7%) | 21 (6%) | 12 (21.1%) | 782 (11.5%) |
| Adjuvants, supplements, and probiotics | 122 (10%) | 3 (16.7%) | 13 (10.1%) | 62 (13.4%) | 30 (13.8%) | 103 (8.8%) | 2 (7.7%) | 300 (11.1%) | 7 (7.3%) | 30 (9.1%) | 47 (13.4%) | 7 (12.3%) | 726 (10.7%) |
| Gastrointestinal | 99 (8.1%) | 1 (5.6%) | 6 (4.7%) | 44 (9.5%) | 12 (5.6%) | 137 (11.7%) | 0 (0%) | 229 (8.4%) | 3 (3.1%) | 6 (1.8%) | 30 (8.5%) | 1 (1.8%) | 568 (8.3%) |
| Antibiotics, antifungals, and antiparasitics | 102 (8.4%) | 0 (0%) | 13 (10.1%) | 25 (5.4%) | 5 (2.3%) | 136 (11.6%) | 1 (3.8%) | 189 (7.0%) | 18 (18.8%) | 10 (3.0%) | 22 (6.3%) | 8 (14.0%) | 529 (7.9%) |
| Cardiovascular (antihypertensives, diuretics, and anticoagulants) | 56 (4.5%) | 0 (0%) | 10 (7.8%) | 28 (6.1%) | 27 (12.5%) | 30 (2.6%) | 10 (38.5%) | 161 (5.9%) | 0 (0%) | 102 (30.8%) | 18 (5.2%) | 1 (1.8%) | 443 (6.5%) |
| Respiratory tract treatments | 75 (6.1%) | 2 (11.1%) | 11 (8.6%) | 15 (3.2%) | 1 (0.5%) | 80 (6.8%) | 1 (3.8%) | 193 (7.1%) | 5 (5.2%) | 13 (3.9%) | 28 (8.0%) | 4 (7.1%) | 428 (6.3%) |
| Medication | 38 (3.1%) | 0 (0%) | 1 (0.8%) | 14 (3%) | 1 (0.5%) | 14 (1.2%) | 2 (7.7%) | 61 (2.3%) | 1 (1%) | 8 (2.4%) | 13 (3.7%) | 5 (8.8%) | 158 (2.3%) |
| Antidiabetics | 1 (0.1%) | 0 (0%) | 12 (9.4%) | 1 (0.2%) | 1 (0.5%) | 2 (0.2%) | 0 (0%) | 17 (0.7%) | 2 (2.0%) | 15 (4.5%) | 3 (0.9%) | 2 (3.6%) | 56 (1.0%) |
| Neurological | 0 (0%) | 0 (0%) | 1 (0.8%) | 1 (0.2%) | 0 (0%) | 3 (0.3%) | 0 (0%) | 3 (0.1%) | 1 (1%) | 0 (0%) | 2 (0.6%) | 0 (0%) | 11 (0.2%) |
| Health orientation and hospital care | 3 (0.3%) | 0 (0%) | 0 (0%) | 1 (0.2%) | 0 (0%) | 1 (0.1%) | 0 (0%) | 11 (0.4%) | 0 (0%) | 1 (0.3%) | 1 (0.3%) | 0 (0%) | 18 (0.2%) |
| Not available | 168 (13.8%) | 5 (27.8%) | 26 (20.2%) | 68 (14.8%) | 41 (18.8%) | 64 (5.5%) | 0 (0%) | 299 (11%) | 9 (9.4%) | 34 (10.3%) | 68 (19.4%) | 10 (17.5%) | 792 (11.7%) |
[i] A = Arena; B = Barletta; C = Borgo Tressanti; D = Contrada Cicerone; E = Madonna di Ripalta; F = Pista; G = San Carlo d’Ascoli; H = Sankara; I = Terlizzi; J = Terraneo; K = Turi; L = Uliveto; NSAIDs = nonsteroidal anti‑inflammatory drugs.
Table 8
Simple logistic regression (unadjusted OR) and multiple logistic regression (adjusted OR) on the probability of returning to the visit with respect to the reference settlement Casa Sankara.
| UNADJUSTED ORS | ADJUSTED OR | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P‑VALUE | OR | 95% CI | P‑VALUE | |
| Settlements | ||||||
| Sankara (H) | ref. | – | – | ref. | – | – |
| Arena (A) | 1.22 | 1.12–1.34 | <0.001 | 1.16 | 1.06–1.28 | 0.002 |
| Barletta (B) | 1.27 | 0.68–2.38 | 0.451 | 1.92 | 1.01–3.65 | 0.045 |
| Borgo Tressanti (C) | 0.51 | 0.37–0.69 | 0.018 | 0.70 | 0.49–1.01 | 0.055 |
| Contrada Cicerone (D) | 1.36 | 1.19–1.56 | <0.001 | 1.34 | 1.18–1.54 | <0.001 |
| Madonna di Ripalta (E) | 1.04 | 0.86–1.26 | 0.692 | 1.64 | 1.29–2.09 | 0.001 |
| Pista (F) | 0.45 | 0.39–0.50 | <0.001 | 0.40 | 0.36–0.46 | <0.001 |
| San Carlo d’Ascoli (G) | 1.00 | 0.58–1.74 | 0.999 | 0.96 | 0.50–1.82 | 0.897 |
| Terlizzi (I) | 0.69 | 0.50–0.96 | 0.025 | 1.02 | 0.71–1.45 | 0.932 |
| Terraneo (J) | 1.47 | 1.27–1.71 | <0.001 | 1.39 | 1.18–1.64 | 0.001 |
| Turi (K) | 0.90 | 0.77–1.06 | 0.208 | 1.41 | 1.14–1.76 | 0.002 |
| Uliveto (L) | 0.35 | 0.21–0.58 | <0.001 | 0.52 | 0.29–0.93 | 0.027 |
| Gender | ||||||
| Male | ref. | – | – | ref. | – | – |
| Female | 0.71 | 0.56–0.90 | 0.005 | 1.10 | 0.83–1.44 | 0.514 |
| Age range at first visit (years) | ||||||
| 0–18 | ref. | – | – | ref. | – | – |
| 19–29 | 0.86 | 0.60–1.23 | 0.401 | 1.00 | 0.67–1.50 | 0.987 |
| 30–45 | 0.81 | 0.57–1.17 | 0.264 | 0.93 | 0.62–1.39 | 0.729 |
| 46–64 | 0.84 | 0.58–1.21 | 0.345 | 0.87 | 0.58–1.30 | 0.492 |
| 65+ | 0.61 | 0.34–1.08 | 0.087 | 0.92 | 0.50–1.71 | 0.804 |
| Country of origin | ||||||
| Other nations | ref. | – | – | ref. | – | – |
| Romania | 2.88 | 1.80–4.6 | <0.001 | 3.09 | 1.79–5.34 | <0.001 |
| Year of first visit | ||||||
| <2022 | ref. | – | – | ref. | – | – |
| 2022–2023 | 0.76 | 0.70–0.83 | <0.001 | 0.60 | 0.52–0.70 | <0.001 |
| Diagnosis of TB | ||||||
| No | ref. | – | – | ref. | – | – |
| Yes | 0.63 | 0.49–0.81 | <0.001 | 0.63 | 0.49–0.81 | <0.001 |
[i] CI = confidence interval; OR = odds ratio
